Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04949087 · ClinicalTrials.gov registry record · NA

Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)

A NA study of Arthritis Shoulder, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT04949087 is a NA study of Arthritis Shoulder that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04949087, a NA study of Arthritis Shoulder, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy of intra-articular corticosteroid injections versus platelet-rich plasma injections for non-operative treatment of primary glenohumeral osteoarthritis. The efficacy of intra-articular injections, outside of hyaluronic acid, for the treatment of glenohumeral OA is not known, yet these treatments are commonly used with hopes of providing patients with symptomatic relief that can hopefully delay or prevent the need for shoulder arthroplasty. This study will help elucidate the therapeutic benefit of corticosteroid and Platelet Rich Plasma (PRP) injections in this patient population.

Conditions Studied

Interventions

  • PROCEDURE Glenohumeral Injection

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-03-13
Est. Completion 2028-01
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT04949087

The ClinicalTrials.gov registry entry for NCT04949087 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthritis Shoulder appearing as the primary indexed condition, and to 1 intervention - of which Glenohumeral Injection is the first listed.

NCT04949087 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04949087 about?

NCT04949087 is a clinical study titled "Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)". The purpose of this study is to compare the efficacy of intra-articular corticosteroid injections versus platelet-rich plasma injections for non-operative treatment of primary glenohumeral osteoarthritis. The efficacy of intra-articular injections, outside of hyaluronic acid, for the treatment of gl...

What is the current status of trial NCT04949087?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-03-13. Estimated completion is 2028-01.

What conditions does trial NCT04949087 study?

This clinical trial studies the following conditions: Arthritis Shoulder.

What interventions are being tested in trial NCT04949087?

The interventions under investigation include: Glenohumeral Injection (PROCEDURE).

Who is sponsoring clinical trial NCT04949087?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04949087 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.